TAG:
cap
New Competitors Line Up In Oncology Marketplace
By Robert Michel | From the Volume XI No. 4 – March 15, 2004 Issue
CEO SUMMARY: Local pathology groups are advised to more closely track developments in the national market for oncology testing. Not only is big money targeting cancer testing, but a number of nimble, entrepreneurial start-up companies have begun to compete for specimens. Genzyme’s acqui…
Side-by-Side Comparison: U.S. Lab Versus British Lab
By Robert Michel | From the Volume XI No. 4 – March 15, 2004 Issue
CEO SUMMARY: Do clinical laboratories in any of the world’s most developed countries have a performance advantage that makes them “best of breed?” Recently, a laboratory in the United States and a laboratory in the United Kingdom had the opportunity to evaluate their financial, prod…
Spectrum Lab Network Expands Into Tennessee
By Robert Michel | From the Volume XI No. 3 – February 23, 2004 Issue
CEO SUMMARY: During the past four years, this energized hospital laboratory joint venture has posted significant growth in its laboratory outreach program. One notable accomplishment has been the effective deployment and use of Web browser-based lab test orders and results reporting with …
New Healthcare Change Cycle Is Opportunity to Fix Problems
By Robert Michel | From the Volume XI No. 3 – February 23, 2004 Issue
CEO SUMMARY: Healthcare’s new cycle of change will be greatly influenced by geneomics, proteomics, the Internet, consumer-driven healthcare, and political decisions that affect the Medicare and Medicaid programs. The launch of a such a new cycle of change presents the laboratory industr…
Price Discount Practices May Prove Troublesome
By Robert Michel | From the Volume XI No. 3 – February 23, 2004 Issue
CEO SUMMARY: Some laboratories continue to offer deeply-discounted prices to the nation’s largest managed care plans as a way to maintain provider status and keep market share. In one case, these deep discounts surprised a long-time lab executive, who decided to share the information, a…
LAB-Interlink Hangs On Despite Financial Woes
By Robert Michel | From the Volume XI No. 2 – February 2, 2004 Issue
CEO SUMMARY: It’s an uphill struggle at LAB-Interlink, based in Omaha, Nebraska. Short of funds, staffed with only a few employees, and urgently seeking capital, the company has so far managed to avoid filing for protection under bankruptcy laws. It is an unwelcome turn of events, since…
Free of IMPATH, Tamtron Ready For A New Future
By Robert Michel | From the Volume XI No. 2 – February 2, 2004 Issue
CEO SUMMARY: Tamtron’s fortunes look much brighter with its acquisition by IMPAC Medical Systems, Inc., a healthcare information vendor with existing products for radiation oncology, medical oncology, and urology. IMPAC’s strategy is to create a “total solution” for oncology. That…
Web Lab Test Ordering Market Is Increasing
By Robert Michel | From the Volume XI No. 2 – February 2, 2004 Issue
CEO SUMMARY: In recent years, the market for browser-based laboratory test ordering and results reporting systems has grown at a steady rate. Second and third generation products are more robust, offer more features, and are easier to install and operate. To date, smaller start-up compani…
More Firms Now Offer Web Lab Info Products
By Robert Michel | From the Volume XI No. 2 – February 2, 2004 Issue
CEO SUMMARY: Since our last vendor directory in winter 2001, the number of companies selling browser-based systems for laboratory testing ordering and results reporting has doubled! That’s a sign that laboratories recognize the need to have an Internet strategy and are taking steps to d…
“February 2, 2004 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XI No. 2 – February 2, 2004 Issue
Changes are afoot in the national market for anatomic pathology services. At AmeriPath, Inc., the search is on for a new CEO. Current Chairman and CEO, James C. New retired, effective February 1. The company has commenced the search for a new CEO. New had been with AmeriPath since it…
CURRENT ISSUE
Volume XXXIII, No. 4 – March 23, 2026
A federal court ruling has established a safe harbor for clinical labs when they run tests ordered by physicians. Lab leaders should examine this briefing for pitfalls. Also, it turns out that providers may be ordering inappropriate vitamin D tests, according to one expert.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized